A Phase 1a/1b Study of ELVN-001 for the Treatment Chronic Myeloid Leukemia
NCT05304377
·
clinicaltrials.gov ↗
PHASE1
Phase
RECRUITING
Status
250
Enrollment
INDUSTRY
Sponsor class
Conditions
Chronic Myeloid Leukemia
Chronic Phase Chronic Myeloid Leukemia, BCR-ABL1 Positive
Cml
Interventions
DRUG:
ELVN-001
Sponsor
Enliven Therapeutics